NEW YORK (GenomeWeb News) – Bruker today reported that its third-quarter revenues increased 7 percent year over year, easily beating consensus Wall Street estimates on the top and bottom line.

The Billerica, Mass.-based scientific instruments maker reported total revenues of $447.8 million for the three months ended Sept. 30, compared to $418.4 million. Analysts, on average, had forecasted $421.4 million in sales.

Excluding the effects of acquisitions and foreign currency translation, Bruker's Q3 revenues were up 14 percent year over year.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.